Science Explorer Back to mapMap
Discussion
Researcher · Asklepios Klinik Altona · Germany

Hans Jürgen Salwender

Hans Jürgen Salwender publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors and Cancer Treatment and Pharmacology.

ORCID 0000-0001-7803-0814 OpenAlex
World rank
#448,220
of 7,710,434 ranked researchers
Rank in Germany
#22,021
of 364,343
Works
256
Citations
9k
Citations per work
35.0
h-index
46
i10-index 108Top 4.5% in Hematology
Hans Jürgen Salwender

What does Hans Jürgen Salwender research?

Hans Jürgen Salwender's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (21%).

Health Sciences: 154 works · 60.2% of their workMedicine: 154 works · 60.2% of their workHematology: 86 works · 33.6% of their workOncology: 43 works · 16.9% of their workGenetics: 12 works · 4.5% of their workPathology and Forensic Medicine: 7 works · 2.8% of their workPublic Health, Environmental and Occupational Health: 6 works · 2.4% of their workLife Sciences: 53 works · 20.6% of their workBiochemistry, Genetics and Molecular Biology: 53 works · 20.6% of their workMolecular Biology: 53 works · 20.6% of their workEverything else: 49 works · 19.2% of their workTHEIR WORKHans JürgenSalwender256works
Life Sciences21%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine15460.2%
    1. Biochemistry, Genetics and Molecular Biology5320.6%
  3. Everything else4919.2%
  1. 1Hematology34% of their works
  2. 2Molecular Biology21% of their works
  3. 3Oncology17% of their works
  4. 4Genetics4% of their works
  5. 5Pathology and Forensic Medicine3% of their works
  6. 6Public Health, Environmental and Occupational Health2% of their works

Research topics

Which keywords describe Hans Jürgen Salwender's research?

The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, BET Bromodomains, PROTACs, Prognostic Factors, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and Acute Myeloid Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Diagnosis Criteria1781 topic
  2. International Myeloma Working Group1781 topic
  3. BET Bromodomains871 topic
  4. PROTACs871 topic
  5. Prognostic Factors592 topics
  6. Chemotherapy-Induced Peripheral Neuropathy581 topic
  7. Taxanes581 topic
  8. AML401 topic
  9. Acute Myeloid Leukemia401 topic
  10. Fibroblast Activation Protein321 topic
  11. Tumor Microenvironment321 topic
  12. Chronic Lymphocytic Leukemia191 topic
  13. DNA191 topic
  14. Genomic Aberrations191 topic
  15. Topoisomerases191 topic
  16. Acute Promyelocytic Leukemia111 topic
  17. Retinoic Acid111 topic

Where does Hans Jürgen Salwender work?

Hans Jürgen Salwender's main affiliation in the publication record is Asklepios Klinik Altona, Germany.

How many publications and citations does Hans Jürgen Salwender have?

OpenAlex counts 256 works and 8,969 citations for Hans Jürgen Salwender, an h-index of 46, ranking #448,220 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hans Jürgen Salwender. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.